Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease

Gut

Volumn 43, Issue 1, 1998, Pages 33-39

  Stokkers, P C F ^a   Van Aken, B E ^a   Basoski, N ^a   Reitsma, P H ^a   Tytgat, G N J ^a   Van Deventer, S J H ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Crohn's disease; Cytokine gene polymorphisms; Interleukin 1 receptor antagonist; Interleukin 1 ; Ulcerative colitis

Indexed keywords

DNA; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ULCERATIVE COLITIS;

EID: 0031813286     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.1.33     Document Type: Article

References (47)

1. Duerr RH. Genetics of inflammatory bowel disease (review). Inflamm Bowel Dis 1996;2:48-60.
2. Satsangi J, Jewell P. Genetic markers in inflammatory bowel disease. Curr Opin Gastroenterol 1996;12:322-6.
3. Satsangi J, Welsh KI, Bunce M, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996;347:1212-7.
4. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Linkage analyses of chromosome 6 loci, including HLA, in familial aggregations of Crohn's disease. Am J Med Genet 1994;52:207-13.
5. Plevy SE, Targan SR, Yang H, et al. Tumor necrosis factor microsatellites define a Crohn's disease-associated haplotype on chromosome 6. Gastroenterology 1996;110:1053-60.
6. Satsangi J, Parkes M, Louis R, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 1996;14:199-202.
7. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996;379:821-3.
8. Ohmen JD, Yang HY, Yamamoto KK, et al. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis. Hum Mol Genet 1996;5:1679-83.
9. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med 1993;328:106-13.
10. Dinarello CA, Thompson RC. Blocking IL-1: interleukin-1 receptor antagonist in vivo and in vitro. Immunol Today 1991;12:404-10.
11. Hannum CH, Wilcox CJ, Arend WP, et al. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 1990;343:336-40.
12. Ligumsky M, Simon PL, Karmeli F, et al. Role of interleukin-1 in inflammatory bowel disease-enhanced production during active disease. Gut 1990;31:686-9.
13. Nakamura M, Saito H, Kasanuki J, et al. Cytokine production in patients with inflammatory bowel disease. Gut 1992;33:933-7.
14. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin-1β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 1989; 30:835-8.
15. Casini-Raggi V, Kam L, Chong YL, et al. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation. J Immunol 1995;154:2434-40.
16. Mansfield JC, Holden H, Tarlow JK, et al. Novel genetic association between ulcerative colitis and the antiinflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994;106:637-42.
17. Duerr RH, Tran T. Association between ulcerative colitis and a polymorphism in intron 2 of the interleukin-1 receptor antagonist gene [abstract]. Gastroenterology 1995;108: A812.
18. Tountas NA, Kam L, Digiovine FS, et al. Genetic association between allele 2 of IL-1 receptor antagonist (IL-1 ra) and ulcerative colitis in a Los Angeles based Hispanic population [abstract]. Gastroenterology 1995;108: A930.
19. Louis E, Satsangi J, Roussomoustakaki M, et al. Cytokine gene polymorphisms in inflammatory bowel disease. Gut 1996;39:705-10.
20. Bioque G, Crusius JBA, Koutroubakis I, et al. Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1 RA) genes in inflammatory bowel disease. Clin Exp Immunol 1995;102:379-83.
21. Heresbach D, Alizadeh M, Dabadie A, et al. Significance of interleukin-1β and interleukin-1 receptor antagonist in inflammatory bowel diseases. Am J Gastroenterol 1997;92: 1164-9.
22. Pociot F, Molvig J, Wogensen L, et al. A TaqI polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 1992;22:396-402.
23. Danis VA, Millington M, Hyland VJ, et al. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995;99:303-10.
24. Andus T, Vogl D, Ashenbrenner E, et al. IL-1 ra genotype 2 is associated with reduced IL-1ra in colonic mucosa [abstract]. Gastroenterology 1996;108:A3070.
25. Webb AC, Collins KL, Auron PE, et al. Interleukin-1 gene (IL-1) assigned to long arm of chromosome 2. Lymphokine Res 1986;5:77-85.
26. Furutani Y, Notake M, Fukui T, et al. Complete nucleotide sequence of the gene for human interleukin 1 alpha. Nucleic Acids Res 1986;14:3167-74.
27. Modi WS, Masuda A, Yamada M, et al. Chromosomal localization of the human interleukin-1α (IL1α) gene. Genomics 1988;2:310-14.
28. Lafage M, Maroc N, Dubreuil P, et al. The human interleukin-1α gene is located on the long arm of chromosome 2 at hand q13. Blood 1989;73:104-7.
29. Steinkasserer A, Spurr NK, Cox S, et al. The human IL-1 receptor antagonist gene (IL1RN) maps to chromosome 2q14 21, in the region of the IL-1α and IL-1β loci. Genomics 1992;13:654-7.
30. Patterson D, Jones C, Hart I, et al. The human interleukin-1 receptor antagonist is located in the chromosome 2q14 region. Genomics 1993;15:173-6.
31. Lennard A, Gorman P, Carrier M, et al. Cloning and chromosome mapping of the interleukin-1 receptor antagonist gene. Cytokine 1993;4:83-9.
32. Guash JF, Bertina RM, Reitsma P. Five novel intragenic dimorphisms in the human interleukin-1 genes combine to high informativity. Cytokine 1996;8:598-602.
33. Sambrook J, Fritsch EF, Maniatis T. In: Molecular cloning. 2nd edn. New York: Cold Spring Harbor Laboratory, 1989:16-19.
34. Clay JF, Tarlow JK, Cork MJ, et al. Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele specific mRNA assessment. Hum Genet 1996;97:723-6.
35. Entzian P, Linneman K, Schlaak M, Zabel P. Obstructive sleep apnea syndrome and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 1996;153:1080-6.
36. Nerad JL, Griffiths JK, Van der Meer JWM, et al. Interleukin-1β (IL-1β), interleukin-1 receptor antagonist, and TNFα production in whole blood. J Leukoc Biol 1992; 52:687-92.
37. De Groote D, Zangerle PF, Gevaert Y, et al. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992;4:239-48.
38. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995;59:97-105.
39. Altman DG. Comparing risks. In: Practical statistics for medical research. 1st edn. London: Chapman & Hall, 1993: 266-8.
40. Rachmilewitz D, Simon PL, Schwartz LW, et al. Inflammatory mediators of experimental colitis in rats. Gastroenterology 1989;97:326-37.
41. Cominelli F, Nast CC, Clark BD, et al. Interleukin-1 (IL1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J Clin Invest 1990;86:972-80.
42. Tarlow JK, Blakemore AIF, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable number of an R6-bp tandem repeat. Hum Genet 1993;91:403-1
43. Andus T, Caesar I, Vogl D, et al. Association of HLA-DR15, pANCA and IL-1 receptor antagonist allele 2 with ulcerative colitis [abstract]. 1995;108:A770.
44. Roussomoustakaki M, Satsangi J, Welsh K, et al. Genetic marker may predict disease behavior in patients with ulcerative colitis. Gastroenterology 1997;112:1845-53.
45. Langholz E, Nielsen OH, Munkholm P, et al. Course and prognostic factors influencing changes in anatomical extent of ulcerative colitis [abstract]. Gastroenterology 1995;108: A857.
46. Hacker UT, Gomolka M, Keller E, et al. Lack of association between an interleukin-1 receptor gene polymorphism and ulcerative colitis. Gut 1997;40:623-7.
47. Granowitz EV, Santos AA, Poutsiaka DD, et al. Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 1991;338:1423-4.